Diabetes Association Blocks Op-Ed Publication

A recent controversy has unfolded involving the American Diabetes Association (ADA) and several researchers who had submitted op-ed articles for publication. The authors, who had been invited to write on the topic of the ADA's 2022 guidelines for the management of blood sugar levels, claim that their submissions were blocked from being published without explanation.

In response to the ADA's decision, the researchers decided to post their articles as preprints, a move that bypasses the traditional peer-review process. Preprints allow authors to share their research findings with the academic community before formal publication. The researchers stated that they wanted to make their work available to the public as soon as possible, as the ADA's guidelines have significant implications for the treatment and management of diabetes. By posting their articles as preprints, the authors are able to maintain control over the dissemination of their research.

The decision by the ADA to block the publication of these op-ed articles has raised questions about the association's editorial policies and the potential for censorship. The researchers' use of preprints has also sparked debate about the role of traditional peer-review processes in the dissemination of scientific knowledge. As the debate continues, the preprinted articles remain available to the public, providing a platform for discussion and scrutiny of the ADA's guidelines.